{
  "nctId": "NCT03607695",
  "briefTitle": "Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease",
  "officialTitle": "Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease",
  "protocolDocument": {
    "nctId": "NCT03607695",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2018-07-26",
    "uploadDate": "2021-07-28T21:01",
    "size": 752524,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03607695/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 19,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-02-01",
    "completionDate": "2020-06-30",
    "primaryCompletionDate": "2020-06-30",
    "firstSubmitDate": "2018-07-24",
    "firstPostDate": "2018-07-31"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Meet UK Brain Bank (UKBB) criteria for the diagnosis of PD (modified so that having more than one affected relative was not considered an exclusion criteria)\n* Have a Hoehn \\& Yahr score of 3\n* Have the ability to walk 400 m without physical assistance from a device or another person\n* Do not have other health conditions (e.g., orthopedic, cardiopulmonary) that impact the ability to safely participate in a moderately intense gait training program\n\nExclusion Criteria:\n\n* The investigators will exclude those patients presenting clinical diagnosis of dementia.\n* The investigators will exclude those patients presenting conditions (cardiac, renal, or metabolic) that would pose a risk to their health by exercising.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "50 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Gait Speed (m/s)",
        "description": "The investigators will use the APDM Movement Monitoring system to assess gait speed (m/s) during straight-line walking as a measure of gait function.",
        "timeFrame": "measured at baseline, 2 weeks, 10 weeks and 16 weeks"
      },
      {
        "measure": "Montreal Cognitive Assessment Score",
        "description": "The investigators will use the Montreal Cognitive Assessment (MoCA; score range=0-30, with 30 indicating better cognitive function) as a reflection of global cognitive function",
        "timeFrame": "measured at baseline and at 10 weeks"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 24,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:45.251Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}